Back to Search
ROBERT DILLMAN, MD FACP
MD FACP
Hematology & Oncology Physician
NPI: 1538225438Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
C038008(CA)
Research & Publications (20)
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.
PMID 19538053·Cancer Biother Radiopharm·2009
8-other
Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.
PMID 19362957·Clin Lung Cancer·2009
3-trial
Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance.
PMID 19208427·Cancer·2009
8-other
Improving survival for patients with breast cancer compared with intramural and extramural benchmarks.
PMID 17386125·Clin Breast Cancer·2007
8-other
Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.
PMID 17651037·Cancer Biother Radiopharm·2007
8-other
Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
PMID 17600465·Cancer Biother Radiopharm·2007
3-trial
Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09.
PMID 16706633·Cancer Biother Radiopharm·2006
3-trial
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.
PMID 16550338·Clin Exp Med·2006
6-review
American Society of Clinical Oncology 41st annual meeting.
PMID 16050788·Expert Opin Biol Ther·2005
6-review
Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?
PMID 16114985·Cancer Biother Radiopharm·2005
8-other
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
PMID 15923802·Am J Clin Oncol·2005
3-trial
Autologous tumor cell line-derived vaccine for patient-specific treatment of advanced renal cell carcinoma.
PMID 15650449·Cancer Biother Radiopharm·2004
8-other
Tumor-infiltrating lymphocytes and interleukin-2: dose and schedules of administration in the treatment of metastatic cancer.
PMID 15665620·Cancer Biother Radiopharm·2004
8-other
Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis.
PMID 15650459·Cancer Biother Radiopharm·2004
3-trial
Phase I/II trial of autologous tumor cell line-derived vaccines for recurrent or metastatic sarcomas.
PMID 15650450·Cancer Biother Radiopharm·2004
3-trial
Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.
PMID 14748654·Expert Rev Anticancer Ther·2004
6-review
Unique aspects of supportive care using monoclonal antibodies in cancer treatment.
PMID 18628130·Support Cancer Ther·2003
8-other
Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the cancer biotherapy research group.
PMID 14629821·Cancer Biother Radiopharm·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- ONE HOAG DRIVE, BLDG 41 HOAG CANCER CENTER
NEWPORT BEACH, CA 92658 - Phone
- (949) 764-8091
Quick Facts
- NPI
- 1538225438
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile